Concepedia

Publication | Open Access

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

DOIFull Paper Access

534

Citations

25

References

2012

Year

Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap,
The Lancet Oncology

References

YearCitations

Page 1